Despite their importance, the development of adjuvants faces several challenges:
Safety Concerns - Ensuring that adjuvants do not cause adverse reactions is paramount. Regulatory Hurdles - The approval process for new adjuvants is stringent, requiring extensive data to demonstrate safety and efficacy. Cost - The research and development process is expensive and time-consuming. Public Perception - Misconceptions and fears about vaccine ingredients can hinder acceptance and uptake.
